Carglumic Acid

CAS : 1188-38-1

Ref. TM-T0755

Informations sur le produit

• Nom: Carglumic Acid
• Synonymes: Carbaglu, N-Carbamylglutamate, N-Carbamyl-L-glutamic acid, Carbamylglutamic acid, Carbamino-L-glutamic acid, Ureidoglutaric acid, (2S)-2-(Carbamoylamino)pentanedioic acid, (S)-2-Ureidopentanedioic acid, <span class="text-smallcaps">L</span>-Glutamic acid, N-(aminocarbonyl)-, Carbaglu, Carbamino-<span class="text-smallcaps">L</span>-glutamic acid, Carbamino-L-glutamic acid, Carbamylglutamic acid, Carglumic acid, Carglumic acid [INN], Glutamic acid, N-carbamoyl-, <span class="text-smallcaps">L</span>-, Glutamic acid, N-carbamoyl-, L- (8CI), L-Glutamic acid, N-(aminocarbonyl)-, L-N-Carbamoylglutamic acid, N-(Aminocarbonyl)-<span class="text-smallcaps">L</span>-glutamic acid, N-(aminocarbonyl)-L-Glutamic acid, N-Carbamoyl-<span class="text-smallcaps">L</span>-glutamic acid, N-Carbamoyl-L-glutamic acid, N-Carbamoyl-S-glutamic acid, N-Carbamyl-<span class="text-smallcaps">L</span>-glutamic acid, N-Carbamylglutamate, NCG, Oe 312, Ucedane, Unii-5L0Hb4V1Ew, Ureidoglutaric acid
• CAS: 1188-38-1

Description

Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 190.15
• Formule: C₆H₁₀N₂O₅
• Degré de pureté: 99.8%
• Couleur/Forme: Solid